查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1522995

肉毒桿菌市場報告：2030 年趨勢、預測與競爭分析

Botulism Illness Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

肉毒桿菌中毒的趨勢與預測

預計 2024 年至 2030 年全球肉毒桿菌市場將以 6.6% 的複合年成長率成長。該市場的主要促進因素是肉毒桿菌中毒發病率的上升和醫療技術領域的進步。全球肉毒桿菌市場的未來看起來充滿希望，零售藥局市場和網路商店市場也充滿機會。

按細分市場分類的肉毒桿菌市場

根據毒素類型、治療類型、藥物分銷管道、最終用途和地區對全球肉毒桿菌市場進行預測。

肉毒桿菌市場洞察

Lucintel 預測，A 型肉毒桿菌產品預計將在預測期內強勁成長。

由於處方藥和醫療保健產品的廣泛使用，零售藥局將繼續成為該市場的重要組成部分。

由於人們對該疾病的認知不斷提高並且先進治療設施的可用性不斷提高，北美在整個預測期內仍將是最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024 年至 2030 年，全球肉毒桿菌市場預計將以 6.6% 的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要促進因素是肉毒桿菌中毒的流行和醫療技術領域的進步。

Q3.市場的主要細分市場是：

A3. 肉毒桿菌市場的未來性廣闊，零售藥局和網路商店市場充滿機會。

Q4.市場的主要企業是：

A4. 處理肉毒桿菌中毒的主要企業如下：

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測 A 型肉毒桿菌將在預測期內經歷高速成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於對肉毒桿菌中毒的認知提高以及先進處理設施的容易獲得，北美在預測期內仍然是最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球肉毒桿菌市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球肉毒桿菌市場趨勢（2018-2023）與預測（2024-2030）
  • 按毒素類型分類的全球肉毒桿菌市場
    • A型肉毒桿菌
    • B型肉毒桿菌
  • 按治療類型分類的全球肉毒桿菌市場
    • 抗毒素
    • 仔細的呼吸道管理
    • 瀉藥
    • Foley導管
    • 其他
  • 按藥品分銷管道分類的全球肉毒桿菌市場
    • 零售藥房
    • 網路商店
  • 按最終用途分類的全球肉毒桿菌市場
    • 醫院/診所
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球肉毒桿菌市場
  • 北美肉毒桿菌市場
  • 歐洲肉毒桿菌市場
  • 亞太肉毒桿菌市場
  • 其他區域肉毒桿菌市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按毒素類型分類的全球肉毒桿菌市場成長機會
    • 按治療類型分類的全球肉毒桿菌市場成長機會
    • 按藥品分銷管道分類的全球肉毒桿菌市場成長機會
    • 全球肉毒桿菌市場成長機會（依最終用途）
    • 按地區分類的全球肉毒桿菌市場成長機會
  • 全球肉毒桿菌市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球肉毒桿菌市場的產能
    • 全球肉毒桿菌市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma
簡介目錄

Botulism Illness Trends and Forecast

The future of the global botulism illness market looks promising with opportunities in the retail pharmacy and online store markets. The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Botulism Illness by Segment

The study includes a forecast for the global botulism illness by toxin type, treatment type, drug distribution channel, end use, and region.

Botulism Illness Market by Toxin Type [Shipment Analysis by Value from 2018 to 2030]:

  • Botulinum Type A
  • Botulinum Type B

Botulism Illness Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antitoxins
  • Meticulous Airway Management
  • Cathartics
  • Foley Catheter
  • Others

Botulism Illness Market by Drug Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacy
  • Online Stores

Botulism Illness Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Others

Botulism Illness Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Botulism Illness Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies botulism illness companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the botulism illness companies profiled in this report include-

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma

Botulism Illness Market Insights

Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Within this market, retail pharmacy will remain larger segment due to widespread accessibility for prescription medication and healthcare products.

North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Features of the Global Botulism Illness Market

Market Size Estimates: Botulism illness market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Botulism illness market size by various segments, such as by toxin type, treatment type, drug distribution channel, end use, and region in terms of value ($B).

Regional Analysis: Botulism illness market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different toxin types, treatment types, drug distribution channels, end uses, and regions for the botulism illness market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the botulism illness market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for botulism illness market?

Answer: The global botulism illness market is expected to grow with a CAGR of 6.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the botulism illness market?

Answer: The major drivers for this market are rising incidence of botulism and progress in the field of medical technologies.

Q3. What are the major segments for botulism illness market?

Answer: The future of the botulism illness market looks promising with opportunities in the retail pharmacy and online store markets.

Q4. Who are the key botulism illness market companies?

Answer: Some of the key botulism illness companies are as follows:

  • Allergan
  • Pfizer
  • AlphaVax
  • Microbiotix
  • Molecular Targeting Technologies
  • Ipsen Technologies
  • Galderma

Q5. Which botulism illness market segment will be the largest in future?

Answer: Lucintel forecasts that botulinum type A is expected to witness higher growth over the forecast period.

Q6. In botulism illness market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing awareness about the disease and easy availability of advanced treatment facilities in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the botulism illness market by toxin type (botulinum type A and botulinum type B), treatment type (antitoxins, meticulous airway management, cathartics, foley catheter, and others), drug distribution channel (retail pharmacy and online stores), end use (hospitals & clinics and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Botulism Illness Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Botulism Illness Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Botulism Illness Market by Toxin Type
    • 3.3.1: Botulinum Type A
    • 3.3.2: Botulinum Type B
  • 3.4: Global Botulism Illness Market by Treatment Type
    • 3.4.1: Antitoxins
    • 3.4.2: Meticulous Airway Management
    • 3.4.3: Cathartics
    • 3.4.4: Foley catheter
    • 3.4.5: Others
  • 3.5: Global Botulism Illness Market by Drug Distribution Channel
    • 3.5.1: Retail Pharmacy
    • 3.5.2: Online Stores
  • 3.6: Global Botulism Illness Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Botulism Illness Market by Region
  • 4.2: North American Botulism Illness Market
    • 4.2.1: North American Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.2.2: North American Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
  • 4.3: European Botulism Illness Market
    • 4.3.1: European Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.3.2: European Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
  • 4.4: APAC Botulism Illness Market
    • 4.4.1: APAC Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.4.2: APAC Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores
  • 4.5: ROW Botulism Illness Market
    • 4.5.1: ROW Botulism Illness Market by Toxin Type: Botulinum Type A and Botulinum Type B
    • 4.5.2: ROW Botulism Illness Market by Drug Distribution Channel: Retail Pharmacy and Online Stores

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Botulism Illness Market by Toxin Type
    • 6.1.2: Growth Opportunities for the Global Botulism Illness Market by Treatment Type
    • 6.1.3: Growth Opportunities for the Global Botulism Illness Market by Drug Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Botulism Illness Market by End Use
    • 6.1.5: Growth Opportunities for the Global Botulism Illness Market by Region
  • 6.2: Emerging Trends in the Global Botulism Illness Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Botulism Illness Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Botulism Illness Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Allergan
  • 7.2: Pfizer
  • 7.3: AlphaVax
  • 7.4: Microbiotix
  • 7.5: Molecular Targeting Technologies
  • 7.6: Ipsen Technologies
  • 7.7: Galderma